568 related articles for article (PubMed ID: 30865638)
1. Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages.
Lee HJ; Ko HJ; Kim SH; Jung YJ
PLoS One; 2019; 14(3):e0199799. PubMed ID: 30865638
[TBL] [Abstract][Full Text] [Related]
2. Guttiferone K Exerts the Anti-inflammatory Effect on Mycobacterium Tuberculosis- (H37Ra-) Infected Macrophages by Targeting the TLR/IRAK-1 Mediated Akt and NF-
Zhang Q; Sun J; Fu Y; He W; Li Y; Tan H; Xu H; Jiang X
Mediators Inflamm; 2020; 2020():8528901. PubMed ID: 33100904
[No Abstract] [Full Text] [Related]
3. Polysaccharide rich extract (PRE) from Tinospora cordifolia inhibits the intracellular survival of drug resistant strains of Mycobacterium tuberculosis in macrophages by nitric oxide induction.
Gupta PK; Kulkarni S
Tuberculosis (Edinb); 2018 Dec; 113():81-90. PubMed ID: 30514517
[TBL] [Abstract][Full Text] [Related]
4. Thymoquinone (TQ) inhibits the replication of intracellular Mycobacterium tuberculosis in macrophages and modulates nitric oxide production.
Mahmud HA; Seo H; Kim S; Islam MI; Nam KW; Cho HD; Song HY
BMC Complement Altern Med; 2017 May; 17(1):279. PubMed ID: 28545436
[TBL] [Abstract][Full Text] [Related]
5. Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis-infected macrophages.
Genestet C; Bernard-Barret F; Hodille E; Ginevra C; Ader F; Goutelle S; Lina G; Dumitrescu O;
Tuberculosis (Edinb); 2018 Jul; 111():67-70. PubMed ID: 30029917
[TBL] [Abstract][Full Text] [Related]
6. Bazedoxifene Suppresses Intracellular Mycobacterium tuberculosis Growth by Enhancing Autophagy.
Ouyang Q; Zhang K; Lin D; Feng CG; Cai Y; Chen X
mSphere; 2020 Apr; 5(2):. PubMed ID: 32269154
[TBL] [Abstract][Full Text] [Related]
7. Ursolic Acid Promotes Autophagy by Inhibiting Akt/mTOR and TNF-α/TNFR1 Signaling Pathways to Alleviate Pyroptosis and Necroptosis in Mycobacterium tuberculosis-Infected Macrophages.
Shen J; Fu Y; Liu F; Ning B; Jiang X
Inflammation; 2023 Oct; 46(5):1749-1763. PubMed ID: 37212951
[TBL] [Abstract][Full Text] [Related]
8. Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of
Pahari S; Negi S; Aqdas M; Arnett E; Schlesinger LS; Agrewala JN
Autophagy; 2020 Jun; 16(6):1021-1043. PubMed ID: 31462144
[TBL] [Abstract][Full Text] [Related]
9. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
10. Autophagy: A new strategy for host-directed therapy of tuberculosis.
Paik S; Kim JK; Chung C; Jo EK
Virulence; 2019 Dec; 10(1):448-459. PubMed ID: 30322337
[TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses.
Means TK; Jones BW; Schromm AB; Shurtleff BA; Smith JA; Keane J; Golenbock DT; Vogel SN; Fenton MJ
J Immunol; 2001 Mar; 166(6):4074-82. PubMed ID: 11238656
[TBL] [Abstract][Full Text] [Related]
13. MptpB Promotes Mycobacteria Survival by Inhibiting the Expression of Inflammatory Mediators and Cell Apoptosis in Macrophages.
Fan L; Wu X; Jin C; Li F; Xiong S; Dong Y
Front Cell Infect Microbiol; 2018; 8():171. PubMed ID: 29888212
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes.
Howard NC; Marin ND; Ahmed M; Rosa BA; Martin J; Bambouskova M; Sergushichev A; Loginicheva E; Kurepina N; Rangel-Moreno J; Chen L; Kreiswirth BN; Klein RS; Balada-Llasat JM; Torrelles JB; Amarasinghe GK; Mitreva M; Artyomov MN; Hsu FF; Mathema B; Khader SA
Nat Microbiol; 2018 Oct; 3(10):1099-1108. PubMed ID: 30224802
[TBL] [Abstract][Full Text] [Related]
15. Novel high throughput pooled shRNA screening identifies NQO1 as a potential drug target for host directed therapy for tuberculosis.
Li Q; Karim AF; Ding X; Das B; Dobrowolski C; Gibson RM; Quiñones-Mateu ME; Karn J; Rojas RE
Sci Rep; 2016 Jun; 6():27566. PubMed ID: 27297123
[TBL] [Abstract][Full Text] [Related]
16. Functional Inhibition of Host Histone Deacetylases (HDACs) Enhances
Moreira JD; Koch BEV; van Veen S; Walburg KV; Vrieling F; Mara Pinto Dabés Guimarães T; Meijer AH; Spaink HP; Ottenhoff THM; Haks MC; Heemskerk MT
Front Immunol; 2020; 11():36. PubMed ID: 32117228
[TBL] [Abstract][Full Text] [Related]
17. Different Signaling Pathways Define Different Interferon-Stimulated Gene Expression during Mycobacteria Infection in Macrophages.
Zhou X; Yang J; Zhang Z; Zhang L; Zhu B; Lie L; Huang Y; Ma R; Zhou C; Hu S; Wen Q; Ma L
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717477
[TBL] [Abstract][Full Text] [Related]
18. Engineering zinc oxide hybrid selenium nanoparticles for synergetic anti-tuberculosis treatment by combining Mycobacterium tuberculosis killings and host cell immunological inhibition.
Lin W; Fan S; Liao K; Huang Y; Cong Y; Zhang J; Jin H; Zhao Y; Ruan Y; Lu H; Yang F; Wu C; Zhao D; Fu Z; Zheng B; Xu JF; Pi J
Front Cell Infect Microbiol; 2022; 12():1074533. PubMed ID: 36776549
[TBL] [Abstract][Full Text] [Related]
19. B and T lymphocyte attenuator regulates autophagy in mycobacterial infection via the AKT/mTOR signal pathway.
Liu J; Ming S; Song W; Meng X; Xiao Q; Wu M; Wu Y; Xie H; Zhou J; Zhong H; Huang X
Int Immunopharmacol; 2021 Feb; 91():107215. PubMed ID: 33348294
[TBL] [Abstract][Full Text] [Related]
20. RELL1 inhibits autophagy pathway and regulates Mycobacterium tuberculosis survival in macrophages.
Feng L; Hu J; Zhang W; Dong Y; Xiong S; Dong C
Tuberculosis (Edinb); 2020 Jan; 120():101900. PubMed ID: 32090861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
